Heart Failure Clinical Trial
Official title:
Hormone KLOTHO Level in Heart Failure Patients That Participate in Rehabilitation Programme
30 patients suffering from Heart Failure with Ejection Fraction less than 40% start Cardiac
Rehabilitation Programme, serum KLOTHO Hormone level and other labs and Echo measurements
will be taken on the first visit.
After completion of 3-month Rehabilitation Programme the second set of labs and Echo
measurements will be taken.
Than participants will be divided for 2 groups: the patients who wish to continue
Rehabilitation programme for additional 3-month period and the second group that prefer to
stop Rehabilitation programme after completion of the first 3 month period.
For both groups additional set of labs will be taken this time and at the end of the study.
The Aim of the study: to investigate association between serum KLOTHO level, physical
activity and possible correlation with laboratory and echocardiographic parameters in cohort
of Heart Failure patients.
30 patients, age range older than 18 years old suffering from Heart Failure, Functional
capacity II-III and echocardiographic evidence of Left Ventricular Ejection Fraction less
than 40% beginning Cardiac Rehabilitation Programme. Following recruitment of patients to
the study each one will undergo serum KLOTHO Hormone level assessment along with kidney
functions, N terminal -Pro B-Type Natriuretic Peptide hormone activity and Echo measurements
.
After completion of 3-months Exercise based Rehabilitation Programme set at 70-80% of
maximal individual exercise capacity,a second identical set of lab tests and Echo
measurements will be performed.
After than participants will be divided into 2 groups: Group I will comprise patients who
wish to continue Rehabilitation programme for additional 3-months period and the Group II
those who will stop Exercise Rehabilitation programme following completion of the first 3
months.
Both groups will undergo additional set of lab tests at this six-months-point. Except for
the primary and secondary end-points all possible correlations between serum KLOTHO level
and age, sex, Ejection Fraction, functional capacity, N terminal -Pro B-Type Natriuretic
Peptide hormone activity hormone level and kidney function indices will be evaluated.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|